Takeda logo

Takeda Pharmaceuticals: Global Homepage

2025 Annual Integrated Report

2025 Annual Integrated Report

Learn More

Recent News

Filing of Corporate Governance Report to the Tokyo Stock Exchange

CalendarJuly 9, 2025

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

CalendarJune 30, 2025

Takeda Announces Pricing of Unsecured U.S. Dollar-Denominated Senior Guaranteed Notes

CalendarJune 27, 2025

Takeda Announces the Publication of its Annual Report on Form 20-F for FY2024

CalendarJune 25, 2025
View All

We exist to create better health for people and a brighter future for the world. While the science and technology we advance are constantly evolving, our ambition remains. We move science forward, so we can transform more lives.

Better Health, Brighter Future

two women in a laboratory

Join Us

Work with globally diverse colleagues who are committed to bringing Better Health to people and a Brighter Future to the world.
FIND OUT MORE
People shaking hands in office

Investors

Discover our balanced, diverse portfolio and strategy for sustainable, patient-centered and resilient growth.
FIND OUT MORE
man in labcoat

R&D

Fueled by our inherent curiosity, we translate science into highly innovative, life-transforming medicines.
FIND OUT MORE

Our Areas of Focus

Gastrointestinal and Inflammation

Understanding and addressing life-limiting gastrointestinal and inflammatory diseases

Go to Gastrointestinal and Inflammation page

Rare Diseases

Working to transform treatments in immunology, hematology, metabolic and lysosomal storage disorders

Go to Rare Diseases page

Plasma-Derived Therapies

Improving the lives of patients with rare and complex chronic diseases through innovation in plasma

Go to Plasma-Derived Therapies page

Oncology

Aspiring to cure cancer, with inspiration from patients and innovation from everywhere

Go to Oncology page

Neuroscience

Driving medical innovation for patients with neurological diseases

Go to Neuroscience page

Vaccines

Addressing unmet global health needs through vaccine development against infectious diseases

Go to Vaccines page

Sign up for investors newsletter

Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planet

Sign up